Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127582521 | 12758252 | 1 | I | 20160914 | 20160919 | 20160919 | EXP | BR-GLAXOSMITHKLINE-BR2016GSK135232 | GLAXOSMITHKLINE | 0.00 | M | Y | 95.00000 | KG | 20160919 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127582521 | 12758252 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 21077 | 1 | DF | INHALATION POWDER | BID | |||||
| 127582521 | 12758252 | 2 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 1 UNK, QD | U | 0 | 1 | DF | QD | ||||||
| 127582521 | 12758252 | 3 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 1 UNK, QD | U | 0 | 1 | DF | QD | ||||||
| 127582521 | 12758252 | 4 | C | RIVOTRIL | CLONAZEPAM | 1 | U | 0 | |||||||||||
| 127582521 | 12758252 | 5 | C | ANADOR (DIPYRONE) | 2 | Oral | 1 UNK, QD | U | 0 | 1 | DF | QD | |||||||
| 127582521 | 12758252 | 6 | C | NOVALGINA (DIPYRONE) | 2 | Oral | 1 UNK, QD | U | 0 | 1 | DF | QD | |||||||
| 127582521 | 12758252 | 7 | C | LOSARTAN. | LOSARTAN | 1 | UNK | U | 0 | ||||||||||
| 127582521 | 12758252 | 8 | C | HIDROCLOROTIAZIDA | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127582521 | 12758252 | 1 | Chronic obstructive pulmonary disease |
| 127582521 | 12758252 | 2 | Diabetes prophylaxis |
| 127582521 | 12758252 | 3 | Diabetes prophylaxis |
| 127582521 | 12758252 | 4 | Anxiety |
| 127582521 | 12758252 | 5 | Pain |
| 127582521 | 12758252 | 6 | Pain |
| 127582521 | 12758252 | 8 | Diuretic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127582521 | 12758252 | OT |
| 127582521 | 12758252 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127582521 | 12758252 | Apnoea | |
| 127582521 | 12758252 | Arrhythmia | |
| 127582521 | 12758252 | Blood pressure increased | |
| 127582521 | 12758252 | Brain neoplasm benign | |
| 127582521 | 12758252 | Catarrh | |
| 127582521 | 12758252 | Choking sensation | |
| 127582521 | 12758252 | Cough | |
| 127582521 | 12758252 | Dizziness | |
| 127582521 | 12758252 | Dyspnoea | |
| 127582521 | 12758252 | Headache | |
| 127582521 | 12758252 | Hypoxia | |
| 127582521 | 12758252 | Lymphoma | |
| 127582521 | 12758252 | Medication error | |
| 127582521 | 12758252 | Ocular hyperaemia | |
| 127582521 | 12758252 | Snoring | |
| 127582521 | 12758252 | Tendon rupture | |
| 127582521 | 12758252 | Throat irritation | |
| 127582521 | 12758252 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127582521 | 12758252 | 1 | 2013 | 0 | ||
| 127582521 | 12758252 | 5 | 2012 | 0 | ||
| 127582521 | 12758252 | 6 | 2012 | 0 | ||
| 127582521 | 12758252 | 7 | 2005 | 0 | ||
| 127582521 | 12758252 | 8 | 2005 | 0 |